NORTH AMERICA PRECISION MEDICINE MARKET FORECAST 2021-2028

NORTH AMERICA PRECISION MEDICINE MARKET FORECAST 2021-2028

  • March 2021 •
  • 178 pages •
  • Report ID: 6033699 •
  • Format: PDF
KEY FINDINGS
The North America precision medicine market is projected to evolve with a CAGR of 9.67%, over the forecast years of 2021 to 2028. The region’s key market growth drivers include the rising focus of well-established diagnostics manufacturers to expand their portfolio in NGS-based molecular diagnostics, as well as the initiatives undertaken by the government.

MARKET INSIGHTS
The North America precision medicine market growth is assessed through the evaluation of Canada and the United States.With a well-established network of researchers and academic centers, coordinated through Genome Canada and the Canadian Institutes of Health Research (CIHR), Canada is among the global leaders in the field of precision medicine research.

Genome Canada has funded significant and innovative projects, aligning with its vision to mobilize the transformative potential of genomics to benefit Canadians. Moreover, the projects primarily focus on applying precision medicine to the country’s healthcare system.
On the other hand, Science Minister Kirsty Duncan announced a $2 million initiative in 2016.It aimed at creating a network of researchers involved in the projects, in order to evaluate the findings of several major economic and ethical issues associated with the approach.

Similarly, the Ontario Personalized Medicine Network’s (OPMN) key objective is to ensure that the Canadian province, Ontario, is well-equipped to capitalize on the dynamic and transformative technology, essentially revolutionizing the landscape of medical care.The OPMN also helps identify crucial paths to qualify personalized medicine in the province.

Hence, these factors are expected to propel the country’s market growth, during the forecast period.

COMPETITIVE INSIGHTS
Some of the leading firms operating in the region’s market are, Pfizer Inc, Quest Diagnostics, NanoString Technologies, Novartis AG, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. ABBOTT LABORATORIES
2. ASTRA ZENECA PLC
3. BIOCRATES LIFE SCIENCES AG
4. BIO-RAD LABORATORIES INC
5. DANAHER CORPORATION
6. EAGLE GENOMICS LTD
7. ELI LILLY & COMPANY
8. F. HOFFMANN-LA ROCHE
9. INTOMICS
10. LABORATORY CORPORATION OF AMERICA HOLDINGS
11. NANOSTRING TECHNOLOGIES
12. NOVARTIS AG
13. PFIZER INC
14. QIAGEN NV
15. QUEST DIAGNOSTICS INCORPORATED